Overview Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions Status: Completed Trial end date: 2004-11-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg under fasting conditions. Phase: Phase 1 Details Lead Sponsor: Dr. Reddy's Laboratories LimitedTreatments: EphedrineIbuprofenPseudoephedrine